Occidental Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.51M Sell
45,775
-6,954
-13% -$803K 0.65% 48
2025
Q4
$5.55M Buy
52,729
+2,817
+6% +$264K 0.67% 41
2025
Q3
$4.19M Buy
49,912
+1,473
+3% +$121K 0.53% 59
2025
Q2
$3.83M Buy
48,439
+33,785
+231% +$2.69M 0.53% 59
2025
Q1
$1.32M Buy
14,654
+497
+4% +$46.4K 0.2% 94
2024
Q4
$1.41M Buy
14,157
+1,237
+10% +$128K 0.22% 91
2024
Q3
$1.47M Buy
12,920
+33
+0.3% +$3.92K 0.24% 95
2024
Q2
$1.6M Buy
12,887
+1,134
+10% +$146K 0.28% 88
2024
Q1
$1.55M Buy
11,753
+78
+0.7% +$9.61K 0.29% 87
2023
Q4
$1.27M Sell
11,675
-28
-0.2% -$2.91K 0.26% 97
2023
Q3
$1.2M Buy
11,703
+37
+0.3% +$3.99K 0.28% 87
2023
Q2
$1.35M Buy
11,666
+314
+3% +$35.7K 0.3% 93
2023
Q1
$1.21M Sell
11,352
-578
-5% -$62.4K 0.3% 93
2022
Q4
$1.32M Buy
11,930
+34
+0.3% +$3.48K 0.36% 79
2022
Q3
$1.02M Buy
11,896
+390
+3% +$34.8K 0.31% 89
2022
Q2
$1.05M Hold
11,506
0.31% 91
2022
Q1
$944K Sell
11,506
-46
-0.4% -$3.63K 0.24% 99
2021
Q4
$885K Hold
11,552
0.21% 114
2021
Q3
$868K Hold
11,552
0.23% 112
2021
Q2
$898K Sell
11,552
-591
-5% -$44K 0.24% 111
2021
Q1
$893K Buy
12,143
+209
+2% +$15.4K 0.27% 101
2020
Q4
$931K Sell
11,934
-302
-2% -$23.1K 0.31% 89
2020
Q3
$969K Sell
12,236
-629
-5% -$49.3K 0.4% 65
2020
Q2
$949K Sell
12,865
-157
-1% -$11.8K 0.42% 60
2020
Q1
$956K Buy
13,022
+157
+1% +$12.3K 0.48% 44
2019
Q4
$1.12M Hold
12,865
0.46% 43
2019
Q3
$1.03M Hold
12,865
0.43% 39
2019
Q2
$1.03M Sell
12,865
-105
-0.8% -$8.04K 0.46% 41
2019
Q1
$1.03M Sell
12,970
-314
-2% -$23.5K 0.49% 43
2018
Q4
$969K Hold
13,284
0.55% 40
2018
Q3
$899K Hold
13,284
0.45% 51
2018
Q2
$769K Sell
13,284
-1,109
-8% -$62.6K 0.41% 45
2018
Q1
$748K Hold
14,393
0.4% 49
2017
Q4
$773K Sell
14,393
-157
-1% -$8.7K 0.4% 47
2017
Q3
$889K Buy
14,550
+104
+0.7% +$6.3K 0.49% 38
2017
Q2
$883K Sell
14,446
-78
-0.5% -$4.75K 0.53% 37
2017
Q1
$881K Buy
14,524
+838
+6% +$50.8K 0.58% 32
2016
Q4
$769K Sell
13,686
-178
-1% -$10.4K 0.55% 39
2016
Q3
$826K Hold
13,864
0.67% 38
2016
Q2
$762K Buy
13,864
+2,504
+22% +$133K 0.67% 43
2016
Q1
$574K Hold
11,360
0.69% 35
2015
Q4
$638K Sell
11,360
-210
-2% -$10.6K 0.82% 27
2015
Q3
$545K Buy
11,570
+210
+2% +$11.2K 0.76% 32
2015
Q2
$617K Sell
11,360
-615
-5% -$34.5K 0.83% 31
2015
Q1
$657K Sell
11,975
-307
-2% -$17.4K 0.82% 28
2014
Q4
$666K Sell
12,282
-4,218
-26% -$235K 1.01% 26
2014
Q3
$933K Sell
16,500
-181
-1% -$10.2K 1.52% 14
2014
Q2
$921K Sell
16,681
-210
-1% -$11.5K 1.58% 12
2014
Q1
$915K Buy
+16,891
New +$875K 1.63% 14

Other funds holding MRK

Occidental Asset Management's MRK Position: Q1 2026 in Review

Occidental Asset Management reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $803K and leaving 45,775 shares worth $5.51M. The position accounts for 0.65% of the portfolio, ranked #48.

Occidental Asset Management first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $5.55M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Occidental Asset Management held 45,775 shares of Merck worth $5.51M as of Q1 2026.
  • Occidental Asset Management sold 6,954 Merck shares in Q1 2026, an estimated $803K.
  • Merck made up 0.65% of Occidental Asset Management's portfolio in Q1 2026, its #48 holding.
  • Occidental Asset Management first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
  • Occidental Asset Management's Merck position peaked at $5.55M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.